ArticleJournal of medicinal chemistry2022

Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity.

Zhengnan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.